Published in:
01-04-2013 | Editorial
Off-label, but on-target: Use of regadenoson with exercise
Authors:
Robert C. Hendel, MD, Lauren Frost, MD
Published in:
Journal of Nuclear Cardiology
|
Issue 2/2013
Login to get access
Excerpt
Pharmacologic stress testing has evolved considerably during the past 25 years, providing an extension of the benefits of physiologic imaging to those who are unable to undergo maximal exercise testing. Vasodilator stress myocardial perfusion imaging now compromises more than half of nuclear cardiology procedures in the United States,
1 as multiple procedural advances and additional clinical evidence support this procedure as a mainstay in cardiac testing. …